Phenome-Wide Multi-Omics Integration Uncovers Distinct Archetypes of Human Aging
Li, Huifa, Tang, Feilong, Xue, Haochen, Li, Yulong, Zhuang, Xinlin, Zhang, Bin, Segal, Eran, Razzak, Imran
–arXiv.org Artificial Intelligence
Aging is a highly complex and heterogeneous process that progresses at different rates across individuals, making biological age (BA) a more accurate indicator of physiological decline than chronological age. While previous studies have built aging clocks using single-omics data, they often fail to capture the full molecular complexity of human aging. In this work, we leveraged the Human Phenotype Project, a large-scale cohort of 10,000 adults aged 40-70 years, with extensive longitudinal profiling that includes clinical, behavioral, environmental, and multi-omics datasets spanning transcriptomics, lipidomics, metabolomics, and the microbiome. By employing advanced machine learning frameworks capable of modeling nonlinear biological dynamics, we developed and rigorously validated a multi-omics aging clock that robustly predicts diverse health outcomes and future disease risk. Unsupervised clustering of the integrated molecular profiles from multi-omics uncovered distinct biological subtypes of aging, revealing striking heterogeneity in aging trajectories and pinpointing pathway-specific alterations associated with different aging patterns. These findings demonstrate the power of multi-omics integration to decode the molecular landscape of aging and lay the groundwork for personalized healthspan monitoring and precision strategies to prevent age-related diseases.
arXiv.org Artificial Intelligence
Oct-24-2025
- Country:
- Asia > Middle East
- Israel (0.04)
- UAE > Abu Dhabi Emirate
- Abu Dhabi (0.04)
- Europe
- Finland > Uusimaa
- Helsinki (0.04)
- United Kingdom (0.04)
- Finland > Uusimaa
- North America > United States (0.04)
- Asia > Middle East
- Genre:
- Research Report
- Experimental Study (1.00)
- New Finding (1.00)
- Research Report
- Industry:
- Education > Health & Safety
- School Nutrition (0.93)
- Health & Medicine
- Consumer Health (1.00)
- Diagnostic Medicine (1.00)
- Health Care Technology (0.93)
- Pharmaceuticals & Biotechnology (1.00)
- Therapeutic Area
- Cardiology/Vascular Diseases (1.00)
- Endocrinology > Diabetes (0.93)
- Immunology (1.00)
- Education > Health & Safety
- Technology: